Regeneron forms consortium to accelerate gene sequencing project
(Reuters) - Regeneron Pharmaceuticals Inc on Monday announced a collaboration with rival drugmakers that will speed its effort to collect genetic information on 500,000 people in the UK Biobank database, a project it believes could help accelerate new drug discovery and improve approval success rates.
from Reuters: Health News http://reut.rs/2D5Dejx
http://bit.ly/2zwRqiM
January 08, 2018
|
Labels:
health,
Reuters: Health News
|
This entry was posted on January 08, 2018
and is filed under
health
,
Reuters: Health News
.
You can follow any responses to this entry through
the RSS 2.0 feed.
or trackback from your own site.